News

March 25, 2026

Starget Pharma Closes $18M Series A Financing and Announces Strategic Collaboration with Center for Molecular Imaging and Therapy in Louisiana

October 23, 2024

Starget Pharma and Cancer Focus Fund Announce $5.1 Million Investment to Support Phase 1b Clinical Trial of Novel Peptide Radioligand for Precision Cancer Therapy

October 17, 2024

Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development